{
  "schemaVersion": "deck-intelligence.v1",
  "id": "019de076-a4b3-719a-94d2-ca29be1b4679",
  "slug": "0f14c676100503df3bb87c658cc9d332",
  "title": "Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides",
  "subtitle": "Fusion Pharmaceuticals · 2024-01",
  "author": "Fusion Pharmaceuticals",
  "date": "2024-01-01 00:00:00",
  "pageCount": 26,
  "kind": "pitchdeck",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "document": {
    "id": "019de076-a4b3-719a-94d2-ca29be1b4679",
    "slug": "0f14c676100503df3bb87c658cc9d332",
    "title": "Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides",
    "rawTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides",
    "authorId": "fusion-pharmaceuticals",
    "authorName": "Fusion Pharmaceuticals",
    "authorDisplay": "Fusion Pharmaceuticals",
    "kind": {
      "slug": "pitchdeck",
      "label": "Pitch deck"
    },
    "sourceType": {
      "slug": "investor_relations",
      "label": "Investor relations"
    },
    "fileName": "2024-01__fusion-pharmaceuticals__investor-pres__0f14c676.pdf",
    "sourceUrl": "https://www.slidebook.io/company/fusion-pharmaceuticals/presentation/0f14c676100503df3bb87c658cc9d332/",
    "sourceDate": "2024-01-15 00:00:00",
    "presentationDate": "2024-01-01 00:00:00",
    "ingestedAt": "2026-04-30 22:16:05.144413+00",
    "status": "ready",
    "pageCount": 26,
    "orientation": "landscape",
    "aspectRatio": 1.7777778,
    "targetCompany": null,
    "targetTicker": null,
    "metadata": {
      "corpus": "slidebook",
      "industry": "biotechnology",
      "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2024-01__fusion-pharmaceuticals__investor-pres__0f14c676",
      "image_width": 1920,
      "image_format": "jpg",
      "deck_type_raw": "Investor Presentation Deck",
      "deck_type_slug": null,
      "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/"
    }
  },
  "coverage": {
    "pageCount": 26,
    "pagesIndexed": 26,
    "pagesWithImages": 26,
    "pagesWithMetadata": 26,
    "imageCoveragePct": 100,
    "metadataCoveragePct": 100,
    "componentCount": 124,
    "chartCount": 5,
    "metricSlides": 0,
    "toolMatches": 5,
    "documentToolMatches": 0,
    "frameworkMatches": 7,
    "arcMatches": 1,
    "beatMatches": 5,
    "loopMatches": 2,
    "patternMatches": 0,
    "storymakersMatch": false,
    "scoreAvailable": false,
    "reviewAvailable": false,
    "activistThesisAvailable": false,
    "pitchdeckMetadataAvailable": false,
    "pitchdeckProfileAvailable": false
  },
  "blocks": [],
  "matches": {
    "arcs": [
      {
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
        "evidence": "The document follows a structure similar to the Sequoia Pitch, with sections on problem, solution, market sizing, and team",
        "isPrimary": true,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-16 22:42:05.77583+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "beats": [
      {
        "to": 5,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 3,
        "name": "Problem",
        "beatId": "554bdf6e-c16b-49c5-afba-493e028c18d3",
        "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
        "beatType": {
          "name": "Problem",
          "slug": "sequoia-pitch-problem",
          "status": "active",
          "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
          "version": 1,
          "description": null
        },
        "evidence": "The document presents an overview of the radiopharmaceutical space and the potential of FPI-2265",
        "position": 0,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Complication",
          "slug": "complication",
          "status": "active",
          "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
          "version": 1,
          "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 9,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 6,
        "name": "Solution",
        "beatId": "6b3d8599-8ead-4bdc-8ad3-1f9f808d7851",
        "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
        "beatType": {
          "name": "Solution",
          "slug": "sequoia-pitch-solution",
          "status": "active",
          "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
          "version": 1,
          "description": null
        },
        "evidence": "The document presents the solution, including the TATCIST study and Phase 2/3 study initiation",
        "position": 1,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Turn",
          "slug": "turn",
          "status": "active",
          "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
          "version": 1,
          "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 8,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 8,
        "name": "Market Size",
        "beatId": "046b07d8-426c-4b58-b28b-2c0a612b5924",
        "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
        "beatType": {
          "name": "Market Size",
          "slug": "sequoia-pitch-market-size",
          "status": "active",
          "canonId": "019dd9b8-20e6-729c-bc28-05442906d032",
          "version": 1,
          "description": null
        },
        "evidence": "The document presents market sizing information for PLUVICTO patients",
        "position": 2,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Evidence",
          "slug": "evidence",
          "status": "active",
          "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
          "version": 1,
          "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 16,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 16,
        "name": "Competition",
        "beatId": "7c8f287f-efd7-4938-b794-564de09c152d",
        "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
        "beatType": {
          "name": "Competition",
          "slug": "sequoia-pitch-competition",
          "status": "active",
          "canonId": "019dd9b8-21bd-7407-8707-bdf217ed9c76",
          "version": 1,
          "description": null
        },
        "evidence": "The document presents a comparison table of PSMA SMDC vs. PSMA RLT in mCRPC",
        "position": 3,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Evidence",
          "slug": "evidence",
          "status": "active",
          "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
          "version": 1,
          "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 23,
        "arc": {
          "name": "The Sequoia Pitch",
          "slug": "sequoia-pitch",
          "status": "active",
          "bestFor": "Investor pitches, Series A/B, board presentations",
          "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
          "description": null,
          "familyLabel": null,
          "categoryName": "Strategy & Business",
          "categorySlug": "strategy-business"
        },
        "from": 23,
        "name": "Team",
        "beatId": "c1164e95-aa4c-417e-8409-5a25003bb7d3",
        "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
        "beatType": {
          "name": "Team",
          "slug": "sequoia-pitch-team",
          "status": "active",
          "canonId": "019dd9b8-23c9-746f-aaf9-2f5d83892cf3",
          "version": 1,
          "description": null
        },
        "evidence": "The document presents information on Fusion's radiopharmaceutical and oncology drug development expertise",
        "position": 4,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Evidence",
          "slug": "evidence",
          "status": "active",
          "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
          "version": 1,
          "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      }
    ],
    "loops": [
      {
        "to": 11,
        "from": 11,
        "loop": {
          "name": "27_cost_of_inaction",
          "slug": "27-cost-of-inaction",
          "status": "active",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "description": "Quantify what happens if the audience does nothing",
          "familyLabel": null,
          "categoryName": "Urgency",
          "categorySlug": "urgency"
        },
        "matchId": "5a525fa2-3a5d-4e7d-9581-137e28735da1",
        "evidence": "The document presents information on the future of radiopharma and the potential of alpha-emitting radioisotopes",
        "position": 0,
        "objective": "Highlight the importance of alpha-emitting radioisotopes in radiopharma",
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-16 22:42:05.985761+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      },
      {
        "to": 19,
        "from": 17,
        "loop": {
          "name": "47_quick_win_big_bet",
          "slug": "47-quick-win-big-bet",
          "status": "active",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "description": "Separate initiatives into immediate wins and longer-term strategic bets",
          "familyLabel": null,
          "categoryName": "Consulting Framework",
          "categorySlug": "consulting-framework"
        },
        "matchId": "d2860898-6698-492a-878a-e8ba168bf1e1",
        "evidence": "The document presents results for the FPI-1434 Phase 1 Trial, including encouraging safety and early signals of antitumor activity",
        "position": 1,
        "objective": "Present promising results for FPI-1434 Phase 1 Trial",
        "confidence": 0.6,
        "extraction": {
          "at": "2026-07-16 22:42:06.021803+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "tools": [
      {
        "tool": {
          "name": "Audience Definition",
          "slug": "audience-definition",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
          "version": 1,
          "bodyDocId": null,
          "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "f6ec9f62-6bd2-4b47-ba62-0bff6b7319ae",
        "evidence": "The content is tailored to an audience interested in pharmaceuticals and radiopharmaceuticals, indicating an understanding of the audience.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 00:41:03.762786+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 3,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Executive summary",
          "slug": "executive-summary",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
          "version": 1,
          "bodyDocId": null,
          "description": "A condensed view of the entire argument on a single slide / block.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "d67c3767-19ac-4834-9476-f695950d0eff",
        "evidence": "This slide serves as an executive summary, highlighting key points about Fusion's position in the radiopharmaceutical space.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:41:03.724263+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 3,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Section divider",
          "slug": "section-divider",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4c66-707d-8d1f-6e14547134c7",
          "version": 1,
          "bodyDocId": null,
          "description": "A transitional slide marking the start of a new section.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "bcaa94ad-35f0-4661-9074-9fbf2858fde3",
        "evidence": "This slide is a section divider, clearly marking a transition to a new topic.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:41:03.838096+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 4,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Section divider",
          "slug": "section-divider",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4c66-707d-8d1f-6e14547134c7",
          "version": 1,
          "bodyDocId": null,
          "description": "A transitional slide marking the start of a new section.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "b6fa25b3-5210-4a60-b4ac-f45aa46ffd60",
        "evidence": "This slide serves as a section divider, transitioning to a new topic.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:41:04.102105+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 10,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Storytelling: the closing ask",
          "slug": "closing-ask",
          "status": "active",
          "bestFor": null,
          "canonId": "019df269-24e0-70ab-8dd9-983832c1c665",
          "version": 1,
          "bodyDocId": "019df269-24bc-7554-b88d-245127606b8d",
          "description": "The single most important slide in the deck — after the cover. The final",
          "familyLabel": "narrative-block",
          "categoryName": "Narrative & Transformation",
          "categorySlug": "narrative-transformation"
        },
        "agent": "storyteller",
        "layer": "slide",
        "agents": [
          "storyteller"
        ],
        "matchId": "7f77d860-006f-459b-9b15-e3225ee83ecf",
        "evidence": "This slide has a 'Thank You' title and a closing_ask type, which directly corresponds to the 'closing-ask-slide' tool.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 00:41:04.401061+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 26,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      }
    ],
    "frameworks": [
      {
        "matchId": "8e2905ca-0bf3-4b88-b7d7-9c0982e24d63",
        "evidence": "The FPI-2265 Program Evolution section uses a vertical flow to show sequential steps.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:11:30.724+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 6,
        "frameworkName": "process"
      },
      {
        "matchId": "2c08b602-6e25-49b8-8c9d-5624fd5db3c8",
        "evidence": "The slide depicts a sequential clinical trial design flow from Phase 2 to Phase 3.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:11:30.753+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 7,
        "frameworkName": "process"
      },
      {
        "matchId": "ff6313bf-9e0d-4c3a-925e-68d6e62ca3ad",
        "evidence": "The slide presents a sequence of events mapped to specific time periods.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 11:11:30.055+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 9,
        "frameworkName": "timeline"
      },
      {
        "matchId": "cbe47792-9c72-456c-a463-84ce2c86cdad",
        "evidence": "The diagram illustrates the flow from raw material (Ra-225) through production to clinical site.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:11:31.174+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 12,
        "frameworkName": "value-chain"
      },
      {
        "matchId": "096c4c12-ea94-4c75-b627-7ed816840888",
        "evidence": "Pipeline visualization showing development stages over time/phases",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 11:11:31.606+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 15,
        "frameworkName": "gantt-chart"
      },
      {
        "matchId": "6581da11-1d84-4687-9830-c84ea1b74973",
        "evidence": "Side-by-side presentation of two clinical datasets to contrast therapeutic outcomes.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:11:31.889+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 16,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "73edd2ab-985c-404a-99d6-69ba25b69305",
        "evidence": "The slide explicitly shows the transition from 177Lu to 225Ac with a directional arrow and performance comparison.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 11:11:32.649+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 22,
        "frameworkName": "before-after-bridge"
      }
    ],
    "patterns": []
  },
  "storymakers": null,
  "score": null,
  "review": null,
  "activistThesis": null,
  "pitchdeck": {
    "metadata": null,
    "profile": null
  },
  "slides": [
    {
      "page": 1,
      "type": "setup",
      "function": "front_matter",
      "imagePath": "https://imgproxy.kitesheet.com/3CD87Kh6Ys9FB8wMDheyI7wsSjYuDMDZXF-EPsPKYKk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wZjE0YzY3NjEwMDUwM2RmM2JiODdjNjU4Y2M5ZDMzMi9wMDAxLmpwZw",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 23,
        "componentCount": 4,
        "textChars": 125,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.624+00",
          "seconds": 4.625,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/1",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-1",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.88
          },
          "kind": "disclaimer",
          "text": "Copyright © 2024 Fusion Pharmaceuticals Inc. All Rights Reserved",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "91249eb0-a5b2-4746-824a-bc3dc24cf0e7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.35,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "image",
          "text": "Fusion Pharmaceuticals Inc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ec2b78ad-7faf-4a6f-8671-630ce05a348c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.2,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "paragraph",
          "text": "January 2024",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f9fa30b2-4f0a-42cd-acef-5ee4d2cbd557",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.05,
            "y": 0.5
          },
          "kind": "title",
          "text": "Corporate Presentation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2b44cde6-b568-47c9-a44a-012d57304869",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "thumbSrc": "https://imgproxy.kitesheet.com/efVw3scVBkKq5iRn7TZqen-sjRZGKpeR8fEBHT4vo6A/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wZjE0YzY3NjEwMDUwM2RmM2JiODdjNjU4Y2M5ZDMzMi9wMDAxLmpwZw",
      "imagePathAlt": "https://imgproxy.kitesheet.com/cXNhbyvCMaSCC2CzzHd8JrjpsfiLYpBp-iYmcE1mTw0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wZjE0YzY3NjEwMDUwM2RmM2JiODdjNjU4Y2M5ZDMzMi9wMDAxLnBuZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/7un1KRmS3zkDCEPP76UH7MFw_Wae1SQGnlixUMxeQlM/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wZjE0YzY3NjEwMDUwM2RmM2JiODdjNjU4Y2M5ZDMzMi9wMDAxLnBuZw"
    },
    {
      "page": 2,
      "type": "setup",
      "function": "other",
      "rawType": "disclaimer",
      "block": null,
      "metadata": {
        "slideType": "disclaimer",
        "slideTypeCanon": {
          "name": "Disclaimer",
          "slug": "disclaimer",
          "status": "active",
          "canonId": "019de52d-0801-727b-b98a-5ed095aeee78",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 20,
        "componentCount": 3,
        "textChars": 203,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:29.503+00",
          "seconds": 2.182,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/2",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-2",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.75,
            "w": 0.93,
            "x": 0.035,
            "y": 0.18
          },
          "kind": "disclaimer",
          "text": "This presentation contains express or implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:29.503+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "93068949-af86-45ac-aa03-ca27d5470238",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.066,
            "x": 0.909,
            "y": 0.025
          },
          "kind": "image",
          "text": "Fusion Pharmaceuticals Inc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:29.503+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fb17b40-0c29-42f7-aa20-213a48a34aeb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.085,
            "w": 0.375,
            "x": 0.035,
            "y": 0.035
          },
          "kind": "title",
          "text": "Forward-Looking Statements",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:29.503+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "85e783b7-fb73-4afc-b885-a1e00328bedd",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 3,
      "type": "setup",
      "title": "The slide uses a four-column layout to summarize the company's value proposition.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 67,
        "componentCount": 6,
        "textChars": 782,
        "nDataPoints": 0,
        "notes": "The slide uses a four-column layout to summarize the company's value proposition.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:30.642+00",
          "seconds": 3.188,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/3",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-3",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.22,
            "x": 0.75,
            "y": 0.18
          },
          "kind": "list",
          "text": "Platform-Validating Partnership: Collaboration with AstraZeneca leveraging Fusion's platform and deep expertise",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "007598a7-98ba-49bc-9076-499c9afd9e90",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.22,
            "x": 0.27,
            "y": 0.18
          },
          "kind": "list",
          "text": "Actinium & Manufacturing Advantages: Early investments in 225Ac & a fully operational manufacturing facility designed to meet supply demands provides strategic advantage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2064670c-633b-49cd-bab3-d66c1146f4aa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.22,
            "x": 0.51,
            "y": 0.18
          },
          "kind": "list",
          "text": "Diversified Clinical-Stage Pipeline: Novel targeted alpha therapies (TATs) including next-gen ADCs to move the field beyond NETs and prostate cancers",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5ef10357-0c47-4b58-b03d-0500cb5d2df7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.22,
            "x": 0.03,
            "y": 0.18
          },
          "kind": "list",
          "text": "Lead Program AcPSMA in Phase 2/3: Positioned to be first Ac-PSMA targeted radiotherapy to market for treatment of post-lutetium mCRPC, if approved; achieved alignment with FDA on potential registration pathway",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "70daaebd-0c12-4f20-b971-98f1c2050135",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.86
          },
          "kind": "title",
          "text": "Creating cancer therapies by harnessing the potency and precision of targeted alpha therapies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef22c9e2-2aa4-441f-8787-e3d8d712d27c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.6,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Fusion is a Leader in the Radiopharmaceutical Space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ac4391c4-5b73-4ece-81da-ee81da88413a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Audience Definition",
            "slug": "audience-definition",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
            "version": 1,
            "bodyDocId": null,
            "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "f6ec9f62-6bd2-4b47-ba62-0bff6b7319ae",
          "evidence": "The content is tailored to an audience interested in pharmaceuticals and radiopharmaceuticals, indicating an understanding of the audience.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 00:41:03.762786+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 3,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Executive summary",
            "slug": "executive-summary",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
            "version": 1,
            "bodyDocId": null,
            "description": "A condensed view of the entire argument on a single slide / block.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "d67c3767-19ac-4834-9476-f695950d0eff",
          "evidence": "This slide serves as an executive summary, highlighting key points about Fusion's position in the radiopharmaceutical space.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:41:03.724263+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 3,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 5,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 3,
          "name": "Problem",
          "beatId": "554bdf6e-c16b-49c5-afba-493e028c18d3",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Problem",
            "slug": "sequoia-pitch-problem",
            "status": "active",
            "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents an overview of the radiopharmaceutical space and the potential of FPI-2265",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 4,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 13,
        "componentCount": 3,
        "textChars": 86,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:29.84+00",
          "seconds": 2.356,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/4",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-4",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.012,
            "w": 0.336,
            "x": 0.058,
            "y": 0.891
          },
          "kind": "disclaimer",
          "text": "Copyright © 2024 Fusion Pharmaceuticals Inc. All Rights Reserved",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:29.84+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "192e75c9-d3ce-4c2c-aeff-87e224a704cf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.044,
            "w": 0.094,
            "x": 0.881,
            "y": 0.028
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:29.84+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3de254ca-dded-4d6e-94db-098163b20838",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.065,
            "w": 0.483,
            "x": 0.058,
            "y": 0.545
          },
          "kind": "title",
          "text": "Lead Program: FPI-2265",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:29.84+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f16d527-857f-41c2-a75c-cbb7229c0b99",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Section divider",
            "slug": "section-divider",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4c66-707d-8d1f-6e14547134c7",
            "version": 1,
            "bodyDocId": null,
            "description": "A transitional slide marking the start of a new section.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "bcaa94ad-35f0-4661-9074-9fbf2858fde3",
          "evidence": "This slide is a section divider, clearly marking a transition to a new topic.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:41:03.838096+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 4,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 5,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 3,
          "name": "Problem",
          "beatId": "554bdf6e-c16b-49c5-afba-493e028c18d3",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Problem",
            "slug": "sequoia-pitch-problem",
            "status": "active",
            "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents an overview of the radiopharmaceutical space and the potential of FPI-2265",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 5,
      "type": "evidence",
      "title": "The slide uses a before/after PET scan visual to demonstrate clinical efficacy.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 53,
        "componentCount": 4,
        "textChars": 622,
        "nDataPoints": 2,
        "notes": "The slide uses a before/after PET scan visual to demonstrate clinical efficacy.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:33.949+00",
          "seconds": 6.42,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/5",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-5",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.4,
            "x": 0.55,
            "y": 0.18
          },
          "kind": "image",
          "text": "TATCIST Subject #4 - Complete Response (by PSMA-PET scan)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.949+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "81039ef3-2d32-4280-9038-59e8688201ac",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.45,
            "x": 0.03,
            "y": 0.52
          },
          "kind": "list",
          "text": "Potential to change the mCRPC treatment paradigm. FPI-2265 monotherapy: first opportunity is in post-Pluvicto patients. PSMAfore data show opportunity for Pluvicto to move ahead of taxanes; FPI-2265 will follow upline. Potential to expand.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.949+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "13d10627-c1b5-40f3-b8c2-5ada96ff1a4d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.45,
            "x": 0.03,
            "y": 0.18
          },
          "kind": "list",
          "text": "More than 300 patients treated with 225Ac-PSMA globally, including ~100 post-177Lu-PSMA. Achieved clinical POC in mCRPC. Safety results supportive of developability. Responses seen in patients naïve to and treated with 177Lu-PSMA.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.949+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b1eca9d-5292-4371-904c-380f40db3a1c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.7,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "FPI-2265 is Currently the Most Advanced Actinium-Based PSMA Targeted Radiotherapy in Development",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.949+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a747e33e-4dea-4df7-b06f-3e022b322907",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 5,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 3,
          "name": "Problem",
          "beatId": "554bdf6e-c16b-49c5-afba-493e028c18d3",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Problem",
            "slug": "sequoia-pitch-problem",
            "status": "active",
            "canonId": "019dd9b8-1ed4-767b-8e05-40e733bd2311",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents an overview of the radiopharmaceutical space and the potential of FPI-2265",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Complication",
            "slug": "complication",
            "status": "active",
            "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579",
            "version": 1,
            "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 6,
      "type": "evidence",
      "title": "The slide uses a process diagram to show the evolution of the FPI-2265 program.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 56,
        "componentCount": 4,
        "textChars": 790,
        "nDataPoints": 2,
        "notes": "The slide uses a process diagram to show the evolution of the FPI-2265 program.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:30.724+00",
          "seconds": 3.083,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/6",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-6",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.75,
            "w": 0.32,
            "x": 0.65,
            "y": 0.15
          },
          "kind": "diagram",
          "text": "FPI-2265 Program Evolution: IST study initiation -> Fusion acquired TATCIST -> Fusion aligned with FDA -> Fusion to initiate Phase 2/3 study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.724+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dc29e2ee-8ee8-45d7-8445-1bbd34fbe01b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.55,
            "x": 0.03,
            "y": 0.15
          },
          "kind": "list",
          "text": "Expectations for ~25-30 patient Phase 2 data readout: Generally consistent with previously published data; PSA50 response: ~30-50%; Mix of patients who are pre- and post-lutetium, with majority naïve to Pluvicto; Safety profile mostly limited to manageable xerostomia (Grade 1/2) and low rate of high-grade myelotoxicity",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.724+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ceba0186-f887-4807-9028-6702bc3b08b9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.55,
            "x": 0.03,
            "y": 0.58
          },
          "kind": "list",
          "text": "Factors impacting patient response: Number of prior lines of therapies, including 177Lu-PSMA and taxanes; General patient characteristics; e.g. superscan, performance status, liver metastases; PSMA PET uptake (Low PSMA, negative lesions, SUV mean)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.724+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ff6994d5-62af-4a5c-b80e-551e7fc27ecd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.6,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Target Enrollment Complete in TATCIST Study: Data Readout Anticipated in April 2024",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.724+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6342c465-1fb8-4fad-977a-ccf098b4c6fb",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "8e2905ca-0bf3-4b88-b7d7-9c0982e24d63",
          "evidence": "The FPI-2265 Program Evolution section uses a vertical flow to show sequential steps.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:11:30.724+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 6,
          "frameworkName": "process"
        }
      ],
      "arcBeats": [
        {
          "to": 9,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 6,
          "name": "Solution",
          "beatId": "6b3d8599-8ead-4bdc-8ad3-1f9f808d7851",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the solution, including the TATCIST study and Phase 2/3 study initiation",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 7,
      "type": "resolution",
      "title": "The slide uses a process flow diagram to illustrate the transition from Phase 2 (n=60) to Phase 3 (n=550).",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 64,
        "componentCount": 5,
        "textChars": 760,
        "nDataPoints": 2,
        "notes": "The slide uses a process flow diagram to illustrate the transition from Phase 2 (n=60) to Phase 3 (n=550).",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:30.753+00",
          "seconds": 3.097,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/7",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-7",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.45,
            "w": 0.96,
            "x": 0.02,
            "y": 0.5
          },
          "kind": "diagram",
          "text": "Phase 2 (n=60) to Phase 3 (n=550) trial design flow",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.753+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "09caa133-f36f-4ee6-a19a-e5b276a92e81",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.85,
            "x": 0.03,
            "y": 0.26
          },
          "kind": "list",
          "text": "Based on literature and TATCIST data 100 kBq/kg administered every 8 weeks is known to be a safe and active dose regimen. Opportunity to further optimize benefit/risk ratio FPI-2265 prior to initiating the Phase 3 portion of the study. Exploring alternate regimens with higher dosing frequency while keeping cumulative dose and duration of treatment the same. Phase 3 design based on prior precedents: Pivotal open label randomized controlled study of FPI-2265",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.753+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e7b87b33-fc71-4a01-85fb-098c89c1b68c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.75,
            "x": 0.13,
            "y": 0.16
          },
          "kind": "paragraph",
          "text": "Trial designed to select the recommended Phase 3 regimen; completion of enrollment of Phase 2 portion in 2024, consistent with original timelines",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.753+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "621bbbc6-3f6f-4f0c-a6b5-f813d0d653b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.5,
            "x": 0.03,
            "y": 0.07
          },
          "kind": "title",
          "text": "Phase 2/3 Study Initiation Expected in Q2 2024",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.753+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cdf874d0-06bd-4389-86e6-6bbf1ce2b6cb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.7,
            "x": 0.03,
            "y": 0.02
          },
          "kind": "title",
          "text": "Fusion Aligns with FDA on Potential Registrational Pathway",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.753+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ad6d627-9f96-472c-b8b4-87de92b7775d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "2c08b602-6e25-49b8-8c9d-5624fd5db3c8",
          "evidence": "The slide depicts a sequential clinical trial design flow from Phase 2 to Phase 3.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:11:30.753+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 7,
          "frameworkName": "process"
        }
      ],
      "arcBeats": [
        {
          "to": 9,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 6,
          "name": "Solution",
          "beatId": "6b3d8599-8ead-4bdc-8ad3-1f9f808d7851",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the solution, including the TATCIST study and Phase 2/3 study initiation",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 8,
      "type": "resolution",
      "title": "Uses a combination of clinical trial data (VISION) and market projections to justify the TAM for FPI-2265.",
      "function": "size_opportunity",
      "rawType": "market_sizing",
      "block": null,
      "metadata": {
        "slideType": "market_sizing",
        "slideTypeCanon": {
          "name": "Market sizing",
          "slug": "market_sizing",
          "status": "active",
          "canonId": "019de52d-08c8-756c-8664-733b73a7ee7b",
          "version": 1,
          "description": null
        },
        "function": "size_opportunity",
        "functionCanon": {
          "name": "Size opportunity",
          "slug": "size_opportunity",
          "status": "active",
          "canonId": "019de52d-147b-7568-8828-a74a27697618",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 9,
        "textChars": 395,
        "nDataPoints": 12,
        "notes": "Uses a combination of clinical trial data (VISION) and market projections to justify the TAM for FPI-2265.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.228+00",
          "seconds": 3.486,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/8",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-8",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.25,
            "x": 0.72,
            "y": 0.75
          },
          "kind": "callout",
          "text": "Multi-Billion $ in earlier-line pre-Lu setting",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4f3cff07-5ce1-4058-9736-bc76fff454a7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.25,
            "x": 0.72,
            "y": 0.415
          },
          "kind": "callout",
          "text": "Potential FPI-2265 market opportunity: ~$1B in post-Lu setting",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8403b1bf-7a3e-4d4a-9df0-4bfd6717ddbf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.75,
            "x": 0.03,
            "y": 0.86
          },
          "kind": "disclaimer",
          "text": "Source: VISION results per clinicaltrials.gov... *further upside in 1L mCRPC...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "22e1ce5f-6103-48ac-8099-dce6d71fd4fc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.1,
            "x": 0.4,
            "y": 0.25
          },
          "kind": "metric",
          "text": "<10 mo.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0b0704af-0f17-4b8a-84c0-e91b8812ae95",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.1,
            "x": 0.64,
            "y": 0.25
          },
          "kind": "metric",
          "text": "37%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7699964e-e3c9-4c91-acfd-c06e313b7a10",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.1,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "metric",
          "text": "> 50%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "86704ae7-45a4-4f6c-b3df-7fd5a47ef310",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.28,
            "x": 0.18,
            "y": 0.63
          },
          "kind": "table",
          "text": "mCRPC (US+EU4/UK, 2028) 1L 70K, 2L 45K, 3L+ 25K",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "35258cbd-0be5-4a15-8a42-25a2eadbafdd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.28,
            "x": 0.18,
            "y": 0.41
          },
          "kind": "table",
          "text": "mCRPC (US+EU4/UK, 2023) 1L 65K, 2L 42K, 3L+ 24K",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3dc22710-094d-4f69-bd5a-d9ce209aafec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.85,
            "x": 0.03,
            "y": 0.02
          },
          "kind": "title",
          "text": "Significant and Rapidly Growing Market in PLUVICTO™ Patients Expands Potential FPI-2265 Opportunity",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.228+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b56fe292-6daa-4310-b635-091081325875",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 9,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 6,
          "name": "Solution",
          "beatId": "6b3d8599-8ead-4bdc-8ad3-1f9f808d7851",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the solution, including the TATCIST study and Phase 2/3 study initiation",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        },
        {
          "to": 8,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 8,
          "name": "Market Size",
          "beatId": "046b07d8-426c-4b58-b28b-2c0a612b5924",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Market Size",
            "slug": "sequoia-pitch-market-size",
            "status": "active",
            "canonId": "019dd9b8-20e6-729c-bc28-05442906d032",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents market sizing information for PLUVICTO patients",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 9,
      "type": "resolution",
      "function": "plan_implementation",
      "rawType": "timeline",
      "block": null,
      "metadata": {
        "slideType": "timeline",
        "slideTypeCanon": {
          "name": "Timeline",
          "slug": "timeline",
          "status": "active",
          "canonId": "019de52d-0851-75eb-b758-ea2965e7739a",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 26,
        "componentCount": 2,
        "textChars": 279,
        "nDataPoints": 5,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:30.055+00",
          "seconds": 2.258,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/9",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-9",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.62,
            "w": 0.844,
            "x": 0.078,
            "y": 0.209
          },
          "kind": "table",
          "text": "Milestone;Timing;Preliminary TATCIST Data from approximately 25-30 Patients;April 2024;Initiate Phase 2/3 Registration Study;Q2 2024;Initiate Combination Trial with Olaparib;1H 2024;Completion of Phase 2 Study Enrollment;Q4 2024;Phase 3 Initiation;2025",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.055+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "50b1a7c1-a199-489e-85a8-42008b417f83",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.38,
            "x": 0.035,
            "y": 0.035
          },
          "kind": "title",
          "text": "FPI-2265 Program Milestones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.055+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "71dc61af-ec4c-4b3a-bc28-89056a3a0fcc",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ff6313bf-9e0d-4c3a-925e-68d6e62ca3ad",
          "evidence": "The slide presents a sequence of events mapped to specific time periods.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 11:11:30.055+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 9,
          "frameworkName": "timeline"
        }
      ],
      "arcBeats": [
        {
          "to": 9,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 6,
          "name": "Solution",
          "beatId": "6b3d8599-8ead-4bdc-8ad3-1f9f808d7851",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Solution",
            "slug": "sequoia-pitch-solution",
            "status": "active",
            "canonId": "019dd9b8-1fb1-71d9-a260-07738d7f9c2f",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents the solution, including the TATCIST study and Phase 2/3 study initiation",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 10,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 15,
        "componentCount": 3,
        "textChars": 135,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:30.581+00",
          "seconds": 2.746,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/10",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-10",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.05,
            "y": 0.88
          },
          "kind": "disclaimer",
          "text": "Copyright © 2024 Fusion Pharmaceuticals Inc. All Rights Reserved",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f1e73b26-a0c0-455a-b2be-6ac57bfc814f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.1,
            "x": 0.88,
            "y": 0.03
          },
          "kind": "image",
          "text": "Fusion Pharmaceuticals Inc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "18e259ce-d553-4c54-bdba-b12fc0805db7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.6,
            "x": 0.05,
            "y": 0.5
          },
          "kind": "title",
          "text": "Actinium Supply & Manufacturing Capabilities",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f5a10ac-5cf2-4bfb-a6a6-ef1bf08189ac",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Section divider",
            "slug": "section-divider",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4c66-707d-8d1f-6e14547134c7",
            "version": 1,
            "bodyDocId": null,
            "description": "A transitional slide marking the start of a new section.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "b6fa25b3-5210-4a60-b4ac-f45aa46ffd60",
          "evidence": "This slide serves as a section divider, transitioning to a new topic.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:41:04.102105+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 10,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 11,
      "type": "setup",
      "title": "The slide uses a comparative structure to highlight the superiority of alpha particles in DNA damage and clinical logistics.",
      "function": "argue_timing",
      "rawType": "why_now",
      "block": null,
      "metadata": {
        "slideType": "why_now",
        "slideTypeCanon": {
          "name": "Why now",
          "slug": "why_now",
          "status": "active",
          "canonId": "019de52d-0f2e-718d-b8ad-256dd87582d0",
          "version": 1,
          "description": null
        },
        "function": "argue_timing",
        "functionCanon": {
          "name": "Argue timing (why now)",
          "slug": "argue_timing",
          "status": "active",
          "canonId": "019de52d-16f8-74de-9ec2-900be07d90dd",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 5,
        "textChars": 518,
        "nDataPoints": 1,
        "notes": "The slide uses a comparative structure to highlight the superiority of alpha particles in DNA damage and clinical logistics.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:33.969+00",
          "seconds": 6.002,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/11",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-11",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.5,
            "w": 0.2,
            "x": 0.75,
            "y": 0.3
          },
          "kind": "image",
          "text": "Diagram showing Ac-225 decay chain causing DNA double-strand breaks in a cancer cell",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.969+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "61af8f73-40d5-4fea-9ee9-f7e83c1090aa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.35,
            "x": 0.38,
            "y": 0.25
          },
          "kind": "list",
          "text": "10-day half-life; Multiple alpha particles; Superiority in preclinical data; High-level clinical trial safety",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.969+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "22f03744-8b8f-4004-8971-9a8ebe3ba0dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.35,
            "x": 0.03,
            "y": 0.25
          },
          "kind": "list",
          "text": "Double vs single strand DNA breaks; Shorter range/higher energy; Strong immune response; Active in hypoxic tumors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.969+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "70903aaf-e646-46c3-8c4f-496acb5ce4b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.35,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Pouget J-P and Constanzo J (2021) Revisiting the Radiobiology of Targeted Alpha Therapy. Front. Med. 8:692436. doi: 10.3389/fmed.2021.692436",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.969+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2842d600-f06e-4932-ae4e-2933555a702e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.8,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Alpha-Emitting Radioisotopes Represent the Future of Radiopharma",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.969+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "de547b54-ff8f-4334-9056-fb629597a281",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 11,
          "from": 11,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "5a525fa2-3a5d-4e7d-9581-137e28735da1",
          "evidence": "The document presents information on the future of radiopharma and the potential of alpha-emitting radioisotopes",
          "position": 0,
          "objective": "Highlight the importance of alpha-emitting radioisotopes in radiopharma",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:42:05.985761+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 12,
      "type": "setup",
      "title": "The slide highlights a partnership-based supply chain and a proprietary onsite generator technology to mitigate risks associated with traditional cyclotron prod",
      "function": "present_solution",
      "rawType": "unfair_advantage",
      "block": null,
      "metadata": {
        "slideType": "unfair_advantage",
        "slideTypeCanon": {
          "name": "Unfair advantage",
          "slug": "unfair_advantage",
          "status": "active",
          "canonId": "019de52d-0f56-744f-8bb4-c8a8cca240d6",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 73,
        "componentCount": 7,
        "textChars": 785,
        "nDataPoints": 0,
        "notes": "The slide highlights a partnership-based supply chain and a proprietary onsite generator technology to mitigate risks associated with traditional cyclotron production.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.174+00",
          "seconds": 3.201,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/12",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-12",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.94,
            "x": 0.03,
            "y": 0.38
          },
          "kind": "callout",
          "text": "Onsite actinium production builds capacity and flexibility into our manufacturing schedule",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "67b81829-3366-4108-aab6-ae4cfd6928df",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.52,
            "x": 0.45,
            "y": 0.48
          },
          "kind": "diagram",
          "text": "Ra-225 -> Generator -> Ac-225 -> TAT Production -> Clinical Site",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Process flow",
              "slug": "process",
              "status": "active",
              "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "process",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a3668b45-ad67-4e35-adee-9b5fac265cb2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.35,
            "x": 0.6,
            "y": 0.18
          },
          "kind": "image",
          "text": "BWXT Medical, US Department of Energy, Niowave",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo grid",
              "slug": "logo-grid",
              "status": "active",
              "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "54ea5d7e-b51f-498f-8aa5-abdf997b1075",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.33,
            "x": 0.03,
            "y": 0.75
          },
          "kind": "list",
          "text": "Ra-225 continually decays to Ac-225; Ra-225 can be produced from a naturally occurring element",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e88b3277-d271-4d58-9c59-e562e1aea8db",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.33,
            "x": 0.03,
            "y": 0.48
          },
          "kind": "paragraph",
          "text": "Generator technology through collaboration with BWXT Medical enables actinium-225 production on site at Fusion's GMP manufacturing facility without the significant capital investment and operating costs and risks of cyclotron-based methods.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27ac254d-7b33-405e-9cc9-51ba9c48b551",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.55,
            "x": 0.03,
            "y": 0.18
          },
          "kind": "paragraph",
          "text": "Fusion's multiple strategic actinium supply agreements provide preferential access and pricing to actinium and ability to scale to meet anticipated Phase 3 and potential commercial needs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d7ac176e-285c-403b-aaf3-a9fdc7e8daa8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Fusion's Actinium Supply Designed to Provide Execution Advantage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bc767dcb-9f17-41f5-8f93-2024faa830f5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "cbe47792-9c72-456c-a463-84ce2c86cdad",
          "evidence": "The diagram illustrates the flow from raw material (Ra-225) through production to clinical site.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:11:31.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 12,
          "frameworkName": "value-chain"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 13,
      "type": "setup",
      "title": "Highlights internal manufacturing readiness and scale.",
      "function": "present_solution",
      "rawType": "unfair_advantage",
      "block": null,
      "metadata": {
        "slideType": "unfair_advantage",
        "slideTypeCanon": {
          "name": "Unfair advantage",
          "slug": "unfair_advantage",
          "status": "active",
          "canonId": "019de52d-0f56-744f-8bb4-c8a8cca240d6",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 63,
        "componentCount": 6,
        "textChars": 467,
        "nDataPoints": 1,
        "notes": "Highlights internal manufacturing readiness and scale.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:35.362+00",
          "seconds": 7.299,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/13",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-13",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.04,
            "w": 0.85,
            "x": 0.03,
            "y": 0.00185
          },
          "kind": "callout",
          "text": "Internal GMP manufacturing is fully operational: FPI-2265 (225AcPSMA) doses being shipped",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:35.362+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27d023a9-385c-41ee-a927-d6d896d3f5d0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.3,
            "x": 0.03,
            "y": 0.0043
          },
          "kind": "image",
          "text": "Manufacturing facility interior",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:35.362+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5d4c8893-5737-4ac8-89d5-89becb03c5e1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.3,
            "x": 0.35,
            "y": 0.0043
          },
          "kind": "image",
          "text": "Radiopharmaceutical vials",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:35.362+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c4b2f11e-7abe-4627-a7ad-8f50d599d12e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.3,
            "x": 0.67,
            "y": 0.0043
          },
          "kind": "image",
          "text": "Exterior of facility",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:35.362+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cac7fcbc-e785-4d0f-a767-405d251e99bf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.95,
            "x": 0.03,
            "y": 0.0025
          },
          "kind": "list",
          "text": "Clinical & potential commercial supply capabilities\nCapacity designed to produce 100,000+ doses annually\nLocated in an established transportation hub for medical isotopes with decades of experience shipping products globally",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:35.362+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e1ba607d-2e25-42ee-8658-930c91c7338b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.96,
            "x": 0.02,
            "y": 0.03
          },
          "kind": "title",
          "text": "Fusion is Built on a Foundation of Radiopharmaceutical Manufacturing Expertise",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:35.362+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e4bec14-e1a5-47e1-83ee-fb4bd74d3242",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 14,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 17,
        "componentCount": 3,
        "textChars": 166,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:30.642+00",
          "seconds": 2.566,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/14",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-14",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.88
          },
          "kind": "disclaimer",
          "text": "Copyright © 2024 Fusion Pharmaceuticals Inc. All Rights Reserved",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "52d5a89e-d960-41f1-b1a8-b92e41443bd2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.1,
            "x": 0.88,
            "y": 0.03
          },
          "kind": "image",
          "text": "Fusion Pharmaceuticals Inc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "50de526a-36ae-4f2c-a6c5-50d9bf4b4144",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.5
          },
          "kind": "title",
          "text": "Moving the Field Beyond Prostate and NETs: Fusion's Clinical-Stage Pipeline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:30.642+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7ac90fe9-be74-4c28-88ce-8ff0200a12f0",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 15,
      "type": "resolution",
      "title": "The slide uses a standard pharmaceutical pipeline visualization format.",
      "function": "plan_implementation",
      "rawType": "roadmap",
      "block": null,
      "metadata": {
        "slideType": "roadmap",
        "slideTypeCanon": {
          "name": "Roadmap",
          "slug": "roadmap",
          "status": "active",
          "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c",
          "version": 1,
          "description": null
        },
        "function": "plan_implementation",
        "functionCanon": {
          "name": "Plan implementation",
          "slug": "plan_implementation",
          "status": "active",
          "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 42,
        "componentCount": 4,
        "textChars": 338,
        "nDataPoints": 4,
        "notes": "The slide uses a standard pharmaceutical pipeline visualization format.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.606+00",
          "seconds": 3.526,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/15",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-15",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.45,
            "w": 0.94,
            "x": 0.03,
            "y": 0.0031
          },
          "kind": "chart",
          "text": "Pipeline chart showing FPI-2265, FPI-1434, FPI-2059, FPI-2068",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0ad2ff01-e3ca-4a41-aa81-9336d83a93e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.5,
            "x": 0.18,
            "y": 0.0077
          },
          "kind": "paragraph",
          "text": "*Company intends to also pursue combination therapy programs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d955113-c4fb-41e0-83f8-7bec89e921f9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.65,
            "x": 0.18,
            "y": 0.0018
          },
          "kind": "title",
          "text": "Clinical-Stage Pipeline Pursuing a Variety of Solid Tumor Types Including Lung, Ovarian, Sarcoma and Pancreatic",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c13abcbc-b335-4ee2-bf96-b4070647a32a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.85,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Unlocking the Potential of Radiopharmaceuticals in Cancers Outside of the Few Current Approved Indications",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "232ab8ee-f90a-41a5-a82a-a2f542f75397",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "096c4c12-ea94-4c75-b627-7ed816840888",
          "evidence": "Pipeline visualization showing development stages over time/phases",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 15,
          "frameworkName": "gantt-chart"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 16,
      "type": "setup",
      "title": "The slide compares clinical trial data from two different studies (Morris et al. 2017 and Hofman et al. 2018) to illustrate the efficacy of different PSMA-targe",
      "function": "compare_peers",
      "rawType": "comparison_table",
      "block": null,
      "metadata": {
        "slideType": "comparison_table",
        "slideTypeCanon": {
          "name": "Comparison table",
          "slug": "comparison_table",
          "status": "active",
          "canonId": "019de52d-0a06-73f8-8813-fe022fab1de2",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 73,
        "componentCount": 9,
        "textChars": 373,
        "nDataPoints": 2,
        "notes": "The slide compares clinical trial data from two different studies (Morris et al. 2017 and Hofman et al. 2018) to illustrate the efficacy of different PSMA-targeting agents.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.889+00",
          "seconds": 3.794,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/16",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-16",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.5,
            "w": 0.4,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "chart",
          "text": "PSA Best % change from Baseline (Taxane Naive vs Exposed)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d939718e-75b6-4fb2-a311-43b5bd33e327",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.4,
            "x": 0.45,
            "y": 0.31
          },
          "kind": "chart",
          "text": "PSA Best % change from Baseline (Hofman et al.)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fe9d35bf-5590-4ca0-bfb9-433498dc28a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.3,
            "x": 0.53,
            "y": 0.145
          },
          "kind": "image",
          "text": "Chemical structure of Pluvicto",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "37630fb2-e439-4a47-95d1-4af7f449f9a4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.45,
            "x": 0.03,
            "y": 0.145
          },
          "kind": "image",
          "text": "Chemical structure of EC1169",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a50ec731-11cd-469e-b95d-e89badb48c7a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.12,
            "x": 0.86,
            "y": 0.38
          },
          "kind": "image",
          "text": "Post Treatment Scan",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "568ecd93-aa0c-425e-b6a2-e3bf0f3b3224",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.3,
            "x": 0.05,
            "y": 0.86
          },
          "kind": "source-note",
          "text": "Morris et al. (2017) J Clin Oncol 35, suppl; abstr 5038",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3a17eb51-afb3-4b18-8088-4edffb36dd66",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.3,
            "x": 0.5,
            "y": 0.86
          },
          "kind": "source-note",
          "text": "Hofman et al. (2018) Lancet Oncol 19:825-33",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e0703394-53c8-4752-8a7f-bca8176038b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.3,
            "x": 0.03,
            "y": 0.07
          },
          "kind": "title",
          "text": "PSMA SMDC vs. PSMA RLT in mCRPC",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "07eea6e4-43a7-47dc-8ab0-fb49275e55c0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.03,
            "y": 0.02
          },
          "kind": "title",
          "text": "Fusion's Pipeline: Next Generation ADCs Using Lessons from PSMA",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c13f9cec-086d-492d-941d-301cddc8141f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "6581da11-1d84-4687-9830-c84ea1b74973",
          "evidence": "Side-by-side presentation of two clinical datasets to contrast therapeutic outcomes.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:11:31.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 16,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 16,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 16,
          "name": "Competition",
          "beatId": "7c8f287f-efd7-4938-b794-564de09c152d",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Competition",
            "slug": "sequoia-pitch-competition",
            "status": "active",
            "canonId": "019dd9b8-21bd-7407-8707-bdf217ed9c76",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents a comparison table of PSMA SMDC vs. PSMA RLT in mCRPC",
          "position": 3,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 17,
      "type": "setup",
      "title": "Includes a visual comparison between a 'cold' antibody and the 'hot' FPI-1434 conjugate.",
      "function": "present_solution",
      "rawType": "product_demo",
      "block": null,
      "metadata": {
        "slideType": "product_demo",
        "slideTypeCanon": {
          "name": "Product demo",
          "slug": "product_demo",
          "status": "active",
          "canonId": "019de52d-0f06-7288-84f2-7568c1020fce",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 65,
        "componentCount": 5,
        "textChars": 898,
        "nDataPoints": 1,
        "notes": "Includes a visual comparison between a 'cold' antibody and the 'hot' FPI-1434 conjugate.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.22+00",
          "seconds": 2.955,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/17",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-17",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.3,
            "w": 0.5,
            "x": 0.4,
            "y": 0.6
          },
          "kind": "image",
          "text": "Visual comparison of cold vs hot antibody",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.22+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b0b0ffc0-23b8-44a1-a21c-dc9891f8d5cb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.45,
            "x": 0.03,
            "y": 0.18
          },
          "kind": "list",
          "text": "Using alpha emitters in place of chemical toxins in ADCs represents a significant yet untapped opportunity. Alphas also have the potential to “resurrect” naked antibodies which can target, but not effectively kill, cancer cells.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.22+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "08472ef6-7a4c-4973-99fb-856cbd2c11ee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.45,
            "x": 0.03,
            "y": 0.43
          },
          "kind": "list",
          "text": "IGF-1R: Well-established cancer biomarker found on most solid tumors where blocking the target failed to stop tumor growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.22+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5aac93b3-4657-4406-a554-1694ab725998",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.45,
            "x": 0.52,
            "y": 0.18
          },
          "kind": "list",
          "text": "Fusion’s initial approach involved dosing with the highest possible concentration of radiolabeled antibody. We observed toxicity (thrombocytopenia) at higher doses inhibiting delivery of multiple cycles. Fusion’s second dosing regimen involved pre-administration of a small amount (0.5 mg/kg) of the parent (cold) antibody to reduce off-tumor binding. Results showed improved safety and biodistribution.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.22+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f144bf12-40b5-4e46-b64c-ea619a07f450",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.7,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "FPI-1434 Phase 1 Trial: A First-of-its-Kind Antibody-Based Targeted Alpha Therapy Study for Solid Tumors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.22+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "344662b9-29f1-43ea-b104-6f19c82cda00",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 19,
          "from": 17,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "d2860898-6698-492a-878a-e8ba168bf1e1",
          "evidence": "The document presents results for the FPI-1434 Phase 1 Trial, including encouraging safety and early signals of antitumor activity",
          "position": 1,
          "objective": "Present promising results for FPI-1434 Phase 1 Trial",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:42:06.021803+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 18,
      "type": "evidence",
      "title": "Includes medical imaging (SPECT/CT) comparing baseline vs. cold antibody intervention.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 43,
        "componentCount": 4,
        "textChars": 363,
        "nDataPoints": 3,
        "notes": "Includes medical imaging (SPECT/CT) comparing baseline vs. cold antibody intervention.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.19+00",
          "seconds": 2.82,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/18",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-18",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.52,
            "x": 0.03,
            "y": 0.185
          },
          "kind": "image",
          "text": "Comparison of SPECT/CT scans with and without cold antibody",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "07b1a247-dc45-41ac-8505-475bcb65aafc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.4,
            "x": 0.57,
            "y": 0.35
          },
          "kind": "list",
          "text": "No DLTs, limited to transient Grade 1 or less thrombocytopenia; 2/3 patients showed stable disease; Dose escalated to 25 kBq/kg",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "abf94509-625e-447b-ace2-9f77a58f18ae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.57,
            "y": 0.18
          },
          "kind": "paragraph",
          "text": "In June 2023, Fusion reported data from the first cold+hot dosing cohort at 15 kBq/kg:",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e6c65648-b428-4196-844d-eac70d01daf3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.02,
            "y": 0.02
          },
          "kind": "title",
          "text": "Cohort 1 in Cold+Hot Dosing Regimen Showed Promising Results that Supported Dose Escalation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7738d402-e669-49e9-b8e3-98f70f20a1e9",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 19,
          "from": 17,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "d2860898-6698-492a-878a-e8ba168bf1e1",
          "evidence": "The document presents results for the FPI-1434 Phase 1 Trial, including encouraging safety and early signals of antitumor activity",
          "position": 1,
          "objective": "Present promising results for FPI-1434 Phase 1 Trial",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:42:06.021803+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 19,
      "type": "evidence",
      "title": "Includes before/after PET-CT scan imagery.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 65,
        "componentCount": 6,
        "textChars": 482,
        "nDataPoints": 3,
        "notes": "Includes before/after PET-CT scan imagery.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.636+00",
          "seconds": 3.02,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/19",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-19",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.65,
            "x": 0.32,
            "y": 0.68
          },
          "kind": "callout",
          "text": "Encouraging early results show ability to target solid tumors with antibody-based TATs to create “next-generation ADCs”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1ad28b62-178f-46da-8c62-90048652923c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.25,
            "x": 0.02,
            "y": 0.68
          },
          "kind": "image",
          "text": "Follow up PET-CT 12/21/2023",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "be306062-43eb-4b92-a8ff-fca063e4ed42",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.25,
            "x": 0.02,
            "y": 0.145
          },
          "kind": "image",
          "text": "Baseline PET-CT 09/07/2023",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c44d4c0d-2465-437c-affa-8983cfc10005",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.68,
            "x": 0.29,
            "y": 0.35
          },
          "kind": "list",
          "text": "Activity: One patient (chordoma) showed stable disease; One patient (Ewing sarcoma) showed lesion shrinkage after a single dose",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "910c0a68-33fe-48aa-9926-dd956befa917",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.68,
            "x": 0.29,
            "y": 0.16
          },
          "kind": "list",
          "text": "Safety: 2 out of 3 patients completed DLT period; No DLTs, limited to transient Grade 1 or less thrombocytopenia",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "def1ae1b-ba64-493b-bcd4-0c27fc3771b0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Encouraging Safety and Early Signals of Antitumor Activity at 25 kBq/kg",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "429ef641-6943-4e47-9b8e-7687e8b18e4d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [
        {
          "to": 19,
          "from": 17,
          "loop": {
            "name": "47_quick_win_big_bet",
            "slug": "47-quick-win-big-bet",
            "status": "active",
            "bestFor": "Transformation planning, 100-day plans, resource allocation",
            "canonId": "019dd956-790d-708d-983e-ef9bbc68f741",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
            "description": "Separate initiatives into immediate wins and longer-term strategic bets",
            "familyLabel": null
          },
          "matchId": "d2860898-6698-492a-878a-e8ba168bf1e1",
          "evidence": "The document presents results for the FPI-1434 Phase 1 Trial, including encouraging safety and early signals of antitumor activity",
          "position": 1,
          "objective": "Present promising results for FPI-1434 Phase 1 Trial",
          "confidence": 0.6,
          "extraction": {
            "at": "2026-07-16 22:42:06.021803+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 20,
      "type": "setup",
      "function": "transition",
      "rawType": "section_divider",
      "block": null,
      "metadata": {
        "slideType": "section_divider",
        "slideTypeCanon": {
          "name": "Section divider",
          "slug": "section_divider",
          "status": "active",
          "canonId": "019de52d-066a-7402-9554-6ae504999041",
          "version": 1,
          "description": null
        },
        "function": "transition",
        "functionCanon": {
          "name": "Transition",
          "slug": "transition",
          "status": "active",
          "canonId": "019de52d-1365-7149-92aa-66df859e75fd",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 13,
        "componentCount": 3,
        "textChars": 93,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:33.374+00",
          "seconds": 4.72,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/20",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-20",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.3,
            "x": 0.05,
            "y": 0.88
          },
          "kind": "disclaimer",
          "text": "Copyright © 2024 Fusion Pharmaceuticals Inc. All Rights Reserved",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f6eecf9c-f7c7-487b-8040-01b131b123c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.1,
            "x": 0.88,
            "y": 0.02
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5fa04320-c212-447e-9716-6d2a4910ecf8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.65,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "title",
          "text": "Fusion's Early-Stage Pipeline",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:33.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8957d8f2-79ba-44d0-890e-2f904f6d5843",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 21,
      "type": "evidence",
      "title": "The chart shows a clear dose-dependent reduction in tumor volume compared to vehicle and cold antibody controls.",
      "function": "show_traction",
      "rawType": "traction",
      "block": null,
      "metadata": {
        "slideType": "traction",
        "slideTypeCanon": {
          "name": "Traction",
          "slug": "traction",
          "status": "active",
          "canonId": "019de52d-0edd-72ab-820f-3ebc71a9c542",
          "version": 1,
          "description": null
        },
        "function": "show_traction",
        "functionCanon": {
          "name": "Show traction",
          "slug": "show_traction",
          "status": "active",
          "canonId": "019de52d-16a8-756a-9b38-a7d35420561d",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 61,
        "componentCount": 5,
        "textChars": 649,
        "nDataPoints": 1,
        "notes": "The chart shows a clear dose-dependent reduction in tumor volume compared to vehicle and cold antibody controls.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.898+00",
          "seconds": 3.078,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/21",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-21",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.82
          },
          "kind": "callout",
          "text": "Collaboration leverages AstraZeneca’s antibody engineering and oncology expertise with Fusion’s radiopharmaceutical capabilities to produce novel targeted alpha therapies under co-fund and co-development program",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.898+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cc41b3ec-4e2e-4225-901e-a71aa86f8a6a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.4,
            "x": 0.52,
            "y": 0.35
          },
          "kind": "chart",
          "text": "Non-Small Cell Lung Cancer Model: Durable tumor regression observed in treated mice out to day 40",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.898+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b2ba80cd-cdc8-402f-bea6-11d96153548e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.25,
            "x": 0.15,
            "y": 0.35
          },
          "kind": "image",
          "text": "Bispecific antibody diagram with Ac-225 payload",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.898+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dd83c7c6-60bc-4421-b2bb-48695bd8ee58",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "First Program Under Our Multi-Asset Agreement: Dual targeting of validated EGFR & cMET. Combining the power of actinium and precision targeting of bispecifics to address both EGFR mutant & wild type cancers",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.898+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c99b1818-d1e3-4130-abdd-0499e92f8ffe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.8,
            "x": 0.03,
            "y": 0.02
          },
          "kind": "title",
          "text": "Recognizing the Potential of TATs as Next Generation ADCs with AstraZeneca Collaboration",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.898+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c4253c98-cc26-4515-b951-529ebc0f908b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 22,
      "type": "resolution",
      "title": "The slide uses a 'before-after' logic to explain the transition from 177Lu to 225Ac.",
      "function": "present_solution",
      "rawType": "solution",
      "block": null,
      "metadata": {
        "slideType": "solution",
        "slideTypeCanon": {
          "name": "Solution",
          "slug": "solution",
          "status": "active",
          "canonId": "019de52d-0eb5-72ff-8b70-ba70a4199282",
          "version": 1,
          "description": null
        },
        "function": "present_solution",
        "functionCanon": {
          "name": "Present solution",
          "slug": "present_solution",
          "status": "active",
          "canonId": "019de52d-15b8-71da-bd23-2b767850cbce",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 61,
        "componentCount": 6,
        "textChars": 398,
        "nDataPoints": 2,
        "notes": "The slide uses a 'before-after' logic to explain the transition from 177Lu to 225Ac.",
        "elementsJson": null,
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:32.649+00",
          "seconds": 3.668,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/22",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-22",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.12,
            "w": 0.96,
            "x": 0.02,
            "y": 0.15
          },
          "kind": "callout",
          "text": "Fusion acquired the small molecule 177Lu radiopharmaceutical, IPN-1087, from Ipsen",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:32.649+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dd49cc29-6bdc-46b2-8dfd-c64ad26b8110",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.2,
            "x": 0.58,
            "y": 0.45
          },
          "kind": "chart",
          "text": "Relative tumor volume (RTV) vs Days after treatment initiation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:32.649+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c9061ad2-b70b-4390-af28-6310abe80564",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.25,
            "x": 0.11,
            "y": 0.42
          },
          "kind": "image",
          "text": "Clinical imaging of CRC patient",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:32.649+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "853a814b-f8a9-46d2-94be-7eb5fc1b0bea",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.3,
            "x": 0.02,
            "y": 0.07
          },
          "kind": "paragraph",
          "text": "Currently in Phase 1 dose escalation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:32.649+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f6f6f78-022f-40eb-93cb-39d852b695d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 1,
            "x": 0,
            "y": 0.85
          },
          "kind": "title",
          "text": "FPI-2059 augments Fusion’s portfolio with a small molecule-based TAT in areas where there is high unmet medical need",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:32.649+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4b854e5e-deba-4866-bcc1-ed89d87a7a94",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.75,
            "x": 0.02,
            "y": 0.02
          },
          "kind": "title",
          "text": "FPI-2059: A small molecule TAT targeting Neurotensin Receptor 1 (NTSR1)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:32.649+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9dea120a-f6dc-41fb-9bd8-e64eb231e79a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "73edd2ab-985c-404a-99d6-69ba25b69305",
          "evidence": "The slide explicitly shows the transition from 177Lu to 225Ac with a directional arrow and performance comparison.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 11:11:32.649+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 22,
          "frameworkName": "before-after-bridge"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 23,
      "type": "setup",
      "title": "Includes headshots, titles, key experience bullets, and a grid of company logos representing past experience.",
      "function": "other",
      "rawType": "team_bio",
      "block": null,
      "metadata": {
        "slideType": "team_bio",
        "slideTypeCanon": {
          "name": "Team bio",
          "slug": "team_bio",
          "status": "active",
          "canonId": "019de52d-0a7d-7394-ae5b-037478e71f1e",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 27,
        "componentCount": 4,
        "textChars": 195,
        "nDataPoints": 0,
        "notes": "Includes headshots, titles, key experience bullets, and a grid of company logos representing past experience.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.606+00",
          "seconds": 2.501,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/23",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-23",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.35,
            "w": 0.94,
            "x": 0.03,
            "y": 0.15
          },
          "kind": "image",
          "text": "8 leadership headshots",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Headshot",
              "slug": "headshot",
              "status": "active",
              "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d1fdb34-4911-4df3-a4cb-b5d3955ac1c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.94,
            "x": 0.03,
            "y": 0.78
          },
          "kind": "image",
          "text": "Company logos",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo grid",
              "slug": "logo-grid",
              "status": "active",
              "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo-grid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c596f6e3-39a2-4bbc-b23c-43abf8db333e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.94,
            "x": 0.03,
            "y": 0.5
          },
          "kind": "list",
          "text": "Fusion's team has deep radiopharmaceutical & oncology expertise: [list of 5 experience points]",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "615888cb-a762-4440-902e-d1d84ec66f98",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Fusion's Radiopharmaceutical & Oncology Drug Development Expertise",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.606+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "95026a57-fa04-4cb4-b5d7-2aa8ae002e14",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 23,
          "arc": {
            "name": "The Sequoia Pitch",
            "slug": "sequoia-pitch",
            "status": "active",
            "bestFor": "Investor pitches, Series A/B, board presentations",
            "canonId": "019dd956-5e69-75a7-a0a4-895ac1bc0444",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "Problem -> Solution -> Why Now -> Market Size -> Competition -> Product -> Business Model -> Team -> Financials -> The Ask",
            "description": null,
            "familyLabel": null
          },
          "from": 23,
          "name": "Team",
          "beatId": "c1164e95-aa4c-417e-8409-5a25003bb7d3",
          "matchId": "dacd5063-8fa1-4b6b-9145-b40c0e1d2f23",
          "beatType": {
            "name": "Team",
            "slug": "sequoia-pitch-team",
            "status": "active",
            "canonId": "019dd9b8-23c9-746f-aaf9-2f5d83892cf3",
            "version": 1,
            "description": null
          },
          "evidence": "The document presents information on Fusion's radiopharmaceutical and oncology drug development expertise",
          "position": 4,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Evidence",
            "slug": "evidence",
            "status": "active",
            "canonId": "019dd9b8-03f9-772a-b84a-4f07b415b77a",
            "version": 1,
            "description": "A dedicated proof beat exists in only ~4 arcs (Gambit, Sequoia, AIDA, Monroes). Other arcs embed evidence inline within development."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 24,
      "type": "appendix",
      "title": "Includes a footnote explaining the pro forma cash calculation.",
      "function": "summarize",
      "rawType": "appendix",
      "block": null,
      "metadata": {
        "slideType": "appendix",
        "slideTypeCanon": {
          "name": "Appendix",
          "slug": "appendix",
          "status": "active",
          "canonId": "019de52d-0762-71f8-b564-89ab863301cc",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 58,
        "componentCount": 6,
        "textChars": 340,
        "nDataPoints": 2,
        "notes": "Includes a footnote explaining the pro forma cash calculation.",
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.702+00",
          "seconds": 2.589,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/24",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-24",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.35,
            "x": 0.03,
            "y": 0.25
          },
          "kind": "metric",
          "text": "~$287M*",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": null,
            "subkind": {
              "name": "Big number",
              "slug": "big-number",
              "status": "active",
              "canonId": "019de52c-fc70-70c8-b965-0584548a9204",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "big-number",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.702+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "abbee269-e833-4ecb-9fa3-9b71b94fd80d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.35,
            "x": 0.03,
            "y": 0.7
          },
          "kind": "paragraph",
          "text": "extended into Q4 2025",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.702+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "03e4ce38-8056-4b78-ae14-fdd31f75fcc9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.35,
            "x": 0.03,
            "y": 0.35
          },
          "kind": "paragraph",
          "text": "Pro Forma Cash, Cash Equivalents and Investments",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.702+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9fce3e65-ddf3-4447-9794-f251cc01f6b9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.03,
            "y": 0.85
          },
          "kind": "source-note",
          "text": "*Pro forma 9/30/23 cash, cash equivalents and investments include subsequent proceeds from ATM sales of $65 million and expected draw down of $15 million tranche available under Oxford debt facility",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.702+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2074e768-681e-4d5d-bc2a-08e277f50f7b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.7,
            "w": 0.55,
            "x": 0.43,
            "y": 0.15
          },
          "kind": "table",
          "text": "Milestone and Timing table",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.702+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f4ffdd63-e095-4162-a636-2caa49f46714",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.45,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Unaudited Financials and 2024 Milestones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.702+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0fd28385-5366-4824-b0a5-3e80ae389584",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 25,
      "type": "setup",
      "function": "summarize",
      "rawType": "key_messages",
      "block": null,
      "metadata": {
        "slideType": "key_messages",
        "slideTypeCanon": {
          "name": "Key messages",
          "slug": "key_messages",
          "status": "active",
          "canonId": "019de52d-0712-703f-89f5-bda6688faf3f",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 40,
        "componentCount": 4,
        "textChars": 418,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:34.221+00",
          "seconds": 4.898,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/25",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-25",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.6,
            "w": 0.23,
            "x": 0.63,
            "y": 0.215
          },
          "kind": "list",
          "text": "Creating Next-Generation ADCs: Early evidence that antibodies can precisely and safely deliver an active dose of actinium to solid tumors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:34.221+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "500cd4fa-8f10-4a19-8073-43307396c315",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.23,
            "x": 0.13,
            "y": 0.215
          },
          "kind": "list",
          "text": "Lead Program AcPSMA in Phase 2/3: Achieved alignment with FDA on potential registration pathway",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:34.221+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5cb223cb-9b47-4e0a-9638-a55fe82b1e4d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.23,
            "x": 0.38,
            "y": 0.215
          },
          "kind": "list",
          "text": "Actinium & Manufacturing Advantages: GMP radiopharma manufacturing facility fully operational and producing and shipping clinical doses",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:34.221+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ec310a4f-3e63-423d-97ad-a81eecab6834",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.03,
            "y": 0.03
          },
          "kind": "title",
          "text": "Fusion is a Leader in the Radiopharmaceutical Space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:34.221+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb83118f-404f-41a5-966f-113bf426bd48",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 26,
      "type": "setup",
      "function": "state_next_steps",
      "rawType": "closing_ask",
      "block": null,
      "metadata": {
        "slideType": "closing_ask",
        "slideTypeCanon": {
          "name": "Closing ask",
          "slug": "closing_ask",
          "status": "active",
          "canonId": "019de52d-0aa4-750f-8aa1-8d622dd99f5c",
          "version": 1,
          "description": null
        },
        "function": "state_next_steps",
        "functionCanon": {
          "name": "State next steps",
          "slug": "state_next_steps",
          "status": "active",
          "canonId": "019de52d-14ca-70ac-b534-971f458cdf29",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 22,
        "componentCount": 4,
        "textChars": 120,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": null,
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 11:11:31.806+00",
          "seconds": 2.069,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019de076-a4b3-719a-94d2-ca29be1b4679/26",
        "deck": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679",
        "deckAnchor": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679#slide-26",
        "deckJson": "/decks/019de076-a4b3-719a-94d2-ca29be1b4679.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.88
          },
          "kind": "disclaimer",
          "text": "Copyright © 2024 Fusion Pharmaceuticals Inc. All Rights Reserved",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.806+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7085c800-9468-4c38-80d6-8370333dec53",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.33,
            "w": 0.33,
            "x": 0.05,
            "y": 0.07
          },
          "kind": "image",
          "text": "Fusion Pharmaceuticals Inc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.806+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1d3ce7e7-5ed2-463e-83d4-7c0f81bf7e95",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.35,
            "x": 0.05,
            "y": 0.75
          },
          "kind": "paragraph",
          "text": "www.FusionPharma.com",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.806+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "20977007-3149-4929-915e-746426001112",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.28,
            "x": 0.05,
            "y": 0.53
          },
          "kind": "title",
          "text": "Thank You",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 11:11:31.806+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c019a454-c93f-4a9b-90d0-24b69db63978",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Storytelling: the closing ask",
            "slug": "closing-ask",
            "status": "active",
            "bestFor": null,
            "canonId": "019df269-24e0-70ab-8dd9-983832c1c665",
            "version": 1,
            "bodyDocId": "019df269-24bc-7554-b88d-245127606b8d",
            "description": "The single most important slide in the deck — after the cover. The final",
            "familyLabel": "narrative-block",
            "categoryName": "Narrative & Transformation",
            "categorySlug": "narrative-transformation"
          },
          "agent": "storyteller",
          "layer": "slide",
          "agents": [
            "storyteller"
          ],
          "matchId": "7f77d860-006f-459b-9b15-e3225ee83ecf",
          "evidence": "This slide has a 'Thank You' title and a closing_ask type, which directly corresponds to the 'closing-ask-slide' tool.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 00:41:04.401061+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 26,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    }
  ],
  "arcBeats": [
    {
      "from": 3,
      "to": 5,
      "label": "Problem",
      "description": "The document presents an overview of the radiopharmaceutical space and the potential of FPI-2265"
    },
    {
      "from": 6,
      "to": 9,
      "label": "Solution",
      "description": "The document presents the solution, including the TATCIST study and Phase 2/3 study initiation"
    },
    {
      "from": 8,
      "to": 8,
      "label": "Market Size",
      "description": "The document presents market sizing information for PLUVICTO patients"
    },
    {
      "from": 16,
      "to": 16,
      "label": "Competition",
      "description": "The document presents a comparison table of PSMA SMDC vs. PSMA RLT in mCRPC"
    },
    {
      "from": 23,
      "to": 23,
      "label": "Team",
      "description": "The document presents information on Fusion's radiopharmaceutical and oncology drug development expertise"
    }
  ],
  "loops": [
    {
      "from": 11,
      "to": 11,
      "label": "Cost Of Inaction",
      "description": "Highlight the importance of alpha-emitting radioisotopes in radiopharma"
    },
    {
      "from": 17,
      "to": 19,
      "label": "Quick Win Big Bet",
      "description": "Present promising results for FPI-1434 Phase 1 Trial"
    }
  ]
}